Snake metabolite pTOS hints at a new appetite-control drug path

TL;DR Summary
Researchers identified pTOS, a metabolite produced by python gut bacteria that surges after a meal (more than 1,000-fold); when given to obese mice, it suppressed appetite, leading to about 9% body weight loss over 28 days, without notable changes in energy expenditure or organ size. Unlike GLP-1 drugs that slow gastric emptying, pTOS appears to act on the hypothalamus to regulate hunger. The molecule also exists at low levels in human urine, suggesting potential safety, though clinical applicability requires more research; the findings were published in Nature Metabolism.
- Molecule in python blood could pave way for new obesity drugs, scientists say The Guardian
- Pythons' feast-and-famine life hints at new weight loss pathway Medical Xpress
- Goodness snakes: Pythons’ marvelous metabolisms could lead to new weight loss drugs, CU study finds The Colorado Sun
- Python blood compound could lead to new weight loss therapies News-Medical
- Is This Metabolic Molecule from Pythons the Next Big Weight-Loss Drug? Nautilus | Science Connected
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
2 min
vs 3 min read
Condensed
84%
542 → 88 words
Want the full story? Read the original article
Read on The Guardian